£260M
The Manchester medtech company raised backing from the GMC Life Sciences Fund and NPIF II to expand its team and fulfill commercial contracts.
PC
Pill Connect
Pill Connect builds digital tracking devices to monitor medication adherence in clinical trials.
£261MTotal raised
Manchester medtech business that has developed a digital tracking device to monitor medication adherence in clinical trials. The reusable technology attaches to standard pill bottles to supply real-time dispensing data to pharmaceutical companies.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Current assets
Members only
Employees
Members only
Cash, assets and headcount from Pill Connect's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
JB
James Burnstone
CEO
James is the CEO and former CTO of Pill Connect, having previously completed a PhD and research at The University of Manchester.
LinkedInInvestors
- £260M
- £510K
Funding history
£510K
The funding round was backed by Jonathan Milner, Catapult Ventures and Shallcross Partners to fund regulatory submissions and commercialisation.